Kiromic completes GMP manufacturing facility
Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial
Clinical Research
HIV vaccine candidate VIR1111 enters Phase 1
Vir Biotechnology initiates Phase 1 trial to evaluate a novel HIV vaccine platform
Ketamine infusions prove promising in PTSD
Repeated infusions reduce severity of symptoms in chronic post-traumatic stress disorder
Atossa shares Phase 1 results for AT-301
Preliminary results show safety and tolerability of AT-301 nasal spray for COVID-19
Psoriasis progress
EDP1815 Phase 1b data shared at EADV Virtual
Putting RWD and NHD up against placebo
Results from cTAP indicate both could augment or replace placebo controls in DMD clinical trials
Good news to wake up to
Jazz reports promising results for Xywav in adults with rare sleep disorder
BRIDGE-ing the gap to a new treatment
PRX-102 concludes Phase 3 trial in Fabry disease, improves renal function
HepTcell heads to Phase 2
Altimmune begins Phase 2 clinical trial of HepTcell, an immunotherapeutic for chronic hepatitis B
NIH grants $1.5M to Soligenix
Soligenix gains a $1.5 million Small Business Innovation Research award for COVID-19 and ebola vaccines
